Latest AusBiotech News | Page 7

Patrys’ says preclinical data supports synthetic lethality mechanism
Call for speakers for biggest week in biotech
Immutep announces initiation of new breast cancer trial
Mark Butler announces funding for mitochondrial donation pilot program
National Reconstruction Fund moves closer to reality
FDA grants ‘orphan’ designation to PTX-100 for broader TCL indications
Chimeric Therapeutics advances manufacture of CHM 2101 viral vector
Biotech stocks back on road to recovery, according to latest report
Emyria partners with specialist trauma psychiatric service to advance MDMA-assisted therapy
GreenLight Clinical and Cure Therapeutics look to future collaboration
Starpharma announces appointment of chief financial officer
Embracing equity in life sciences sector
Microba Life Sciences announces new distribution agreements in Europe
Neuren Pharmaceuticals appoints experienced industry executive to board
Australian Cell and Gene Catalyst takes step forward
Incannex launches new trial assessing IHL-675A in rheumatoid arthritis
CSL reports positive results from pivotal late-stage trial of first-in-class garadacimab
AusBiotech to propose overhaul of TGA funding
TGA provisionally approves Moderna’s new bivalent Covid vaccine
Noxopharm to present Sofra study at international LUPUS 2023 conference
Cyban says trial reveals the potential benefit of alternative to invasive intracranial monitoring
Clinical program with the Lambert Initiative expands to include Avecho’s oral cannabidiol
AusBiotech leads Australian Pavilion to BIO with exclusive rate for Australian delegates
Dr Joe Smith reappointed as chair of the Agricultural Biotechnology Council of Australia
Europe approves CSL’s first gene therapy for Haemophilia B
AusBiotech develops report to boost cell and gene manufacturing
Clarity reaches recruitment milestone for neuroendocrine tumour diagnostic trial
AnteoTech announces appointment of chief marketing officer
Unit growth for Cochlear as markets return to pre-pandemic levels
Key franchise delivers for CSL as plasma collections top pre-pandemic levels
WA launches inaugural Health and Medical Research Strategy
Genetic Technologies says new publication highlights benefits of GeneType test
AcuraBio partners with Cytiva to alleviate supply constraints for mRNA, cell and gene therapies
AusBiotech develops first biotech ESG guidance
Dimerix announces successful conclusion of clinical trial review
Argenica Therapeutics releases preclinical study data on its ARG007
Call for feedback on revised clinical quality registries framework
Optiscan Imaging announces collaboration with Canadian-based company
Genetic Technologies announces registered direct offering
Emyria to expand MDMA programs following TGA psychedelic decision ‘
Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC
AusBiotech responds to National Reconstruction Fund consultation
Keynote speaker announced for Women in Life Sciences Luncheon
GTG to form strategic alliance with global testing leader QIAGEN
Antisense Therapeutics announces outcomes in DMD combination animal study
AusBiotech strengthens Board with new appointments
Centenary Institute announces its new executive director
Emyria confirms first dosing for EMD-RX5 Phase 3 trial